Antibody therapies are a type of biologic. They are typically monoclonal antibodies selected to bind to a particular protein (often a cell-surface protein), and produced using recombinant DNA ...

"The development of a novel monoclonal antibody and a knock-in reporter allele ... Deep imaging of LepR+ stromal cells in optically cleared murine bone hemisections. Bone Research.

However, research has been hindered by a lack of effective markers and monoclonal antibodies to accurately ... stromal cells within optically cleared murine bone hemisections.

Despite its vital role in "kick-starting" the immune response, IgD is arguably the least understood antibody, with little known about how it might participate in other parts of the immune system. A ...

In a recent study, scientists have introduced an innovative imaging technique that provides an unparalleled view of the bone marrow’s intricate structure, focusing on leptin receptor-expressing (LepR+ ...

[17] Their method followed a simple principle: fusion of spleen cells from a mouse immunized with an antigen of interest with nonsecretory murine ... clinical monoclonal antibody trials in MS ...

Ideally, the immune system will produce long-lasting antibodies recognizing that specific virus, thereby providing protection. Scientists at Scripps Research have now made a new discovery for some ...

An antibody against FnEDA was evaluated for use as an imaging tool, particularly by using in vivo single-photon emission computed tomography (SPECT) and ex vivo near-infrared (NIR) fluorescence ...

Patients using monoclonal antibody treatment vs standard of care had a significantly lower annualized exacerbation rate (RR, 0.82). Treating eosinophilic chronic obstructive pulmonary disease (COPD) ...